Related Experiment Video
Updated: Jun 12, 2025

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
Published on: August 30, 2017
Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation
Melissa L Lynn1, Jesus Jimenez2, Romi L Castillo1
1Department of Biomedical Engineering (M.L.L., R.L.C., C.G., J.C.T.), University of Arizona, Tucson.
Hypertrophic cardiomyopathy (HCM) mutations cause early diastolic dysfunction by altering the cardiac troponin C-cardiac troponin I interface, reducing PKA accessibility. This molecular insight reveals a potential therapeutic target for HCM treatment.
Area of Science:
- Cardiology
- Molecular Biology
- Biophysics
Background:
- Diastolic dysfunction in hypertrophic cardiomyopathy (HCM) is linked to impaired left ventricular relaxation and calcium handling.
- Early relaxation deficits in preclinical HCM suggest myofilament regulators are involved.
- Molecular mechanisms underlying myofilament dysfunction in HCM remain unclear.
Purpose of the Study:
- To investigate how HCM-specific mutations in cardiac troponin T (cTnT) affect diastolic function at the myofilament level.
- To elucidate the role of the cardiac troponin C (cTnC)-cardiac troponin I (cTnI) interface in mutation-specific diastolic dysfunction.
- To identify potential molecular targets for therapeutic intervention in HCM.
Main Methods:
- Studied HCM mutations R92L-cTnT and Δ160E-cTnT using in vivo, in vitro, and in silico approaches.
- Employed 2D echocardiography, Western blotting, ex vivo hemodynamics, stopped-flow kinetics, time-resolved fluorescence resonance energy transfer (TR-FRET), and molecular dynamics simulations.
- Probed the cTnC-cTnI interface using TR-FRET to assess structural changes and PKA accessibility.
Main Results:
- HCM mutations R92L-cTnT and Δ160E-cTnT exhibited distinct onsets of diastolic dysfunction.
- R92L-cTnT mutation led to early diastolic dysfunction and reduced cTnI phosphorylation.
- TR-FRET revealed mutation-specific structural changes at the cTnC-cTnI interface, repositioning cTnI and affecting PKA consensus sites.
Conclusions:
- Early diastolic dysfunction in HCM can result from allosteric changes at the cTnC-cTnI interface.
- These structural alterations impair protein kinase A (PKA) accessibility, blunting beta-adrenergic response.
- The cTnC-cTnI interface represents a potential molecular target for treating HCM-related diastolic dysfunction.
More Related Videos
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Nitric Oxide Signaling Pathway
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCR Desensitization
G-Protein Gated Ion Channels
Sensory...
GPCRs Regulate Adenylyl Cylase Activity